Horweiz Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 05-12-2024
- Paid Up Capital ₹ 0.50 M
as on 05-12-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 1224.46%
(FY 2020)
- Profit 100.00%
(FY 2020)
- Ebitda 97.76%
(FY 2020)
- Net Worth
- Total Assets 61.06%
(FY 2020)
About Horweiz Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Bhupendra Rathore, Akash Kumar, and Mukesh Mehta serve as directors at the Company.
- CIN/LLPIN
U33119MP2018PTC046755
- Company No.
046755
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Horweiz Pharmaceutical?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhupendra Rathore  | Director | 30-Sep-2018 | Current |
| Akash Kumar | Director | 30-Sep-2018 | Current |
| Mukesh Mehta | Director | 18-Jul-2019 | Current |
Financial Performance of Horweiz Pharmaceutical.
Horweiz Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1224.46% increase. The company also saw a substantial improvement in profitability, with a 100% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Horweiz Pharmaceutical?
In 2019, Horweiz Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Horweiz Pharmaceutical?
Unlock and access historical data on people associated with Horweiz Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Horweiz Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Horweiz Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
